Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Details on Person The tumour suppressor CYLD is a negative regulator of RIG-I-mediated antiviral response

Class:Id	LiteratureReference:936403
_displayName	The tumour suppressor CYLD is a negative regulator of RIG-I-mediated antiviral response
_timestamp	2010-08-22 23:35:47
author	[Person:936431] Friedman, CS [Person:936445] O'Donnell, MA [Person:936454] Legarda-Addison, D [Person:936423] Ng, A [Person:936399] Cardenas, Washington B [Person:936453] Yount, JS [Person:936437] Moran, TM [Person:169059] Basler, CF [Person:936392] Komuro, A [Person:192909] Horvath, CM [Person:936408] Xavier, R [Person:936411] Ting, AT
created	[InstanceEdit:936409] Garapati, P V, 2010-08-22
journal	EMBO Rep
pages	930-6
pubMedIdentifier	18636086
title	The tumour suppressor CYLD is a negative regulator of RIG-I-mediated antiviral response
volume	9
year	2008
(literatureReference)	[Summation:936430] CYLD is an ovarian tumor (OTU) domain-containing deubiquitin... [Summation:5696556] CYLD removes Lys63-linked ubiquitin chains, acting as a nega... [BlackBoxEvent:936390] CYLD mediated deubiquitination of DDX58 (RIG-I) [Homo sapiens]
[Change default viewing format]

No pathways have been reviewed or authored by The tumour suppressor CYLD is a negative regulator of RIG-I-mediated antiviral response (936403)